𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of peptichemio in advanced breast cancer

✍ Scribed by V. Hug; G. N. Hortobagyi; A. U. Buzdar; G. R. Blumenschein; W. Grose; M. A. Burgess; G. P. Bodey


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
445 KB
Volume
45
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II Study of Psychotherapeutic Inte
✍ Marco J. De Vries; Johannes N. Schilder; Cornelis L. Mulder; Adriana M. E. Vranc πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

The effect of psychosocial counseling on tumor progression was studied in 96 cancer patients, who were no longer amenable to regular medical treatment. Patients were offered 12 session of individual experiential-existential counseling, each sessions lasting 1.5 to 2 hours. In addition patients parti

A phase II study of combined 5-fluoroura
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 1 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c

Phase I-II study of ftorafur and methyl-
✍ Robert J. Belt; Ronald Stephens πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 316 KB πŸ‘ 1 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved